Showing results (2451-2460 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|July 30, 2014
A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trialsRita Faria, Manuel Gomes, David Epstein, et al.Pharmacoeconomics|April 2, 2016
Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in IrelandSusanne Schmitz, Laura McCullagh, Roisin Adams, et al.Pharmacoeconomics|July 2, 2016
Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic EvaluationsCynthia P Iglesias, Alexander Thompson, Wolf H Rogowski, et al.Pharmacoeconomics|October 9, 2015
Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries, Emelie Heintz, Andreas Gerber-Grote, et al.Pharmacoeconomics|November 14, 2016
Emergent Challenges in Determining Costs for Economic EvaluationsJosephine C Jacobs, Paul G BarnettPharmacoeconomics|October 21, 2017
The Identification, Review and Synthesis of Health State Utility Values from the LiteratureRoberta Ara, John Brazier, Tessa Peasgood, et al.Pharmacoeconomics|March 10, 2019
Correction to: Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A TutorialBaptiste Leurent, Manuel Gomes, Rita Faria, et al.Pharmacoeconomics|April 15, 2019
Tisagenlecleucel for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia in People Aged up to 25 Years: An Evidence Review Group Perspective of a NICE Single Technology AppraisalMatthew Walton, Sahar Sharif, Mark Simmonds, et al.Pharmacoeconomics|February 11, 2018
Cost-Effectiveness Thresholds: the Past, the Present and the FuturePraveen Thokala, Jessica Ochalek, Ashley A Leech, et al.Pharmacoeconomics|April 22, 2018
Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A TutorialBaptiste Leurent, Manuel Gomes, Rita Faria, et al.Pageof 336